Work

Abstract 4791: Immunosuppressive myeloid cells can be modulated with NRP2-targeting antibody ATYR2810 leading to enhanced anti-tumor immunity

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-4791

Authors: Christoph Burkart, Clara Polizzi, John Hyunkuk Choi, Max Pastenes, Alison Barber, Michael Lim, Leslie Nangle

Institutions: aTyr Pharma (United States), Stanford Medicine, Stanford University

Language: English

Topic: Immune cells in cancer

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409634715

Cites:

Cited by:

Related to: 10